CAS 80928-52-5

(1R)-1,5-anhydro-1-{6-[(2R)-3-carboxy-2-methyl-2-{[(2S,5S,6S)-6-methyl-5-{[(2R,6S)-6-methyl-5-oxo-5,6-dihydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]oxy}propyl]-1,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracen-2-yl}-2,6-dideoxy-4-O-[(2S,5S,6S)-6-methyl-

Description:

The chemical substance with the name "(1R)-1,5-anhydro-1-{6-[(2R)-3-carboxy-2-methyl-2-{[(2S,5S,6S)-6-methyl-5-{[(2R,6S)-6-methyl-5-oxo-5,6-dihydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]oxy}propyl]-1,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracen-2-yl}-2,6-dideoxy-4-O-[(2S,5S,6S)-6-methyl-" and CAS number "80928-52-5" is a complex organic compound characterized by multiple functional groups, including carboxylic acids, hydroxyl groups, and various ether linkages. Its structure suggests it may exhibit significant biological activity, potentially serving as a pharmaceutical agent or a natural product derivative. The presence of multiple stereocenters indicates that it may exist in various stereoisomeric forms, which can influence its reactivity and interaction with biological targets. Additionally, the compound's intricate polycyclic framework, featuring anthracene moieties, may contribute to its optical properties and stability. Overall, this substance exemplifies the complexity often found in organic chemistry, particularly in the design of compounds with potential therapeutic applications.

Formula: C₄₉H₅₈O₁₈

InChI: InChI=1/C49H58O18/c1-22-31(50)11-15-38(60-22)64-34-13-17-40(62-24(34)3)66-48-26(5)59-36(19-33(48)52)28-9-10-30-43(45(28)56)47(58)29-8-7-27(44(55)42(29)46(30)57)20-49(6,21-37(53)54)67-41-18-14-35(25(4)63-41)65-39-16-12-32(51)23(2)61-39/h7-12,15-16,22-26,33-36,38-41,48,52,55-56H,13-14,17-21H2,1-6H3,(H,53,54)/t22-,23-,24-,25-,26+,33+,34-,35-,36+,38-,39-,40-,41-,48+,49+/m0/s1

Vineomycin B2

CAS: 80928-52-5

Vineomycin B2

Formula: C₄₉H₅₈O₁₈

Purity: By hplc: 73% (Typical Value in Batch COA)

Color and Shape: orange solid

Molecular weight: 934.97g/mol

Ref: 54-BIBR1112

Vineomycin B2

CAS: 80928-52-5

Vineomycin B2 is an antitumor antibiotic, which is derived from the fermentation of Streptomyces bacteria. The compound functions through a DNA-binding mode of action, specifically intercalating into the DNA double helix, thus disrupting essential replication and transcription processes. This interference with DNA dynamics inhibits the proliferation of cancerous cells, making it a potent compound in oncology research.

Formula: C₄₉H₅₈O₁₈

Purity: Min. 95%

Molecular weight: 935.00 g/mol

Ref: 3D-FDA92852